New transplant method could reduce Graft-Versus-Host disease in kids
NCT ID NCT04806347
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 27 times
Summary
This early-phase study tests a new way to prepare donor stem cells for transplant in children and young adults with non-cancerous blood diseases. The goal is to remove the cells that cause serious side effects (graft-versus-host disease) while keeping cells that fight infections. Up to 12 participants will receive a transplant from a partially matched donor, and researchers will monitor safety and how well the immune system recovers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BLOOD DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.